Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 29,004 shares at $30.59 ($887K) on 2012-11-19, disclosed to the SEC on 2012-11-21.
Open-market sale of $887k MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.59 | 3,196 | $98K | 11.0% |
| 2 | $30.59 | 5,808 | $178K | 20.0% |
| 3 | $30.59 | 20,000 | $612K | 69.0% |
| Total | $30.59 avg | 29,004 | $887K | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |